Clinical and biochemical outcomes of men undergoing radical prostatectomy or radiation therapy for localized prostate cancer
David Schreiber, Justin Rineer, Jeffrey P. Weiss, Joseph Safdieh, Joseph Weiner, Marvin Rotman, David Schwartz
Radiat Oncol J. 2015;33(1):21-28. Published online 2015 Mar 31 DOI: https://doi.org/10.3857/roj.2015.33.1.21
Citations to this article as recorded by 
Outcomes for Young Men With Localized Intermediate-Risk Prostate Cancer: An Analysis of the NCDB
Samantha Chua, Muhammad M. Qureshi, Graham Boyd, Gretchen A. Gignac, Ariel E. Hirsch
Clinical Genitourinary Cancer.2020; 18(5): e531. CrossRef
The Treatments for Low-Risk Prostate Cancer
Jeong Woo Lee, Jae Young Jeong, In-Chang Cho, Sung Han Kim, Whi-An Kwon, Miyoung Choi, Jeong Kyun Yeo
The Korean Journal of Urological Oncology.2019; 17(1): 7. CrossRef
American Brachytherapy Society Task Group Report: Combination of brachytherapy and external beam radiation for high-risk prostate cancer
Daniel E. Spratt, Payal D. Soni, Patrick W. McLaughlin, Gregory S. Merrick, Richard G. Stock, John C. Blasko, Michael J. Zelefsky
Brachytherapy.2017; 16(1): 1. CrossRef
Salvage high-dose-rate brachytherapy for locally recurrent prostate cancer after primary radiotherapy failure
Piotr Wojcieszek, Marta Szlag, Grzegorz Głowacki, Agnieszka Cholewka, Marzena Gawkowska-Suwińska, Sylwia Kellas-Ślęczka, Brygida Białas, Marek Fijałkowski
Radiotherapy and Oncology.2016; 119(3): 405. CrossRef
Comparison of biochemical recurrence in prostate cancer patients treated with radical prostatectomy or radiotherapy
Dong Soo Kim, Seung Hyun Jeon, Sung-Goo Chang, Sang Hyub Lee
Korean Journal of Urology.2015; 56(10): 703. CrossRef